Skip to main content

Part of UT Health San Antonio

Profiles - UT Health San AntonioProfiles - UT Health Science Center San Antonio

Part of UT Health San Antonio

Menu
  • Home

You are here

  • Profiles Home
  • Faculty Directory
  • Abrahamian, Gregory Avedis
Photo of Dr. Gregory Abrahamian

Contact

210-567-5771

abrahamian@uthscsa.edu

Programs

  • M.D. in Doctor of Medicine

Departments & Divisions

  • Department of Surgery

Institutes & Centers

  • Mays Cancer Center
  • Transplant Center

Research

Research profile

Clinical

Provider profile

Gregory A Abrahamian, M.D. (LtCol USAFR)

Professor of Surgery

Joan Wish Endowed Professorship in Transplant Surgery

Surgical Director of Renal Transplantation

Dr. Gregory Abrahamian specializes in adult and pediatric kidney and liver transplant surgery. Dr. Abrahamian received his medical degree from UT Health San Antonio. He completed his residency and transplant fellowship at Wilford Hall Medical Center in San Antonio,Texas, and Massachusetts General Hospital. 

  • Professional Background

    Education

    • 1999 - Clinical Fellowship - Organ Transplantation - Massachusetts General Hospital
    • 1999 - Clinical Fellowship - Organ Transplantation - Harvard Medical School
    • 1997 - Residency - Surgery - Wilford Hall Medical Center
    • 1996 - Residency - Surgery - Wilford Hall Medical Center
    • 1993 - Internship - Surgery - Wilford Hall Medical Center
    • 1992 - MD - Medicine - University of Texas Health Science in San Antonio
    • 1988 - BS - Environmental Health Science (cum laude) - California State University

    Appointments

    • 9/2009 - Associate Professor/Clinical - University of Texas Health Science Center, Transplant Center
    • 3/2008 - Surgical Director of the Kidney Transplant Program - University Hospital Transplant CenterSan Antonio
    • 2/2005 - Surgical Director of the Kidney Transplant Program - Christus Transplant Institute, Christus Transplant Institute
    • 2/2005 - Division Head of the Kidney Transplant Program - University of Texas Health Science Center at San Antonio, Transplant Center, San Antonio
    • 6/2000 - Staff - Christus Santa Rosa Medical Center, Transplant Center, San Antonio
  • Instruction & Training

    • 7/2014 - Present, Individual Instruction, UT Health
    • 4/2005 - Present, Transplant Morbidity and Mortality Conference, UT Health
    • 4/2005 - Present, UTHSCSA
    • 5/2001 - Present, Rotation Student Supervision, University Hospital
    • 5/2001 - Present, Post Graduate Rotation Supervision
    • 4/2001 - Present, Post Graduate Rotation Supervision, University Hospital
    • 5/2000 - Present, Liver/Renal Transplant-univ Hosp, The University of Texas Health Science Center
    • 5/2000 - Present, Liver/Renal Transplant-univ Hosp, The University of Texas Health Science Center
  • Research & Grants

    Research profile

    Grants

    Private

    Funding Agency Roche Title An open-label, prospective, randomized, controlled, multicenter study assessing fixed dose vs concentration controlled cellcept regimens for patients following a single organ renal transplantation in combination with full dose and reduced dose calcineuri Status Active Period 4/2004 - Present Role Principal Investigator Grant Detail   Funding Agency Roche Title Mycophenolate mofetil in treatment of hepatitis C virus infection Status Complete Period 6/2002 - 1/2029 Role Co-Investigator Grant Detail   Funding Agency Astellas Pharma Global Development Title Astellas CMV Status Complete Period 1/2014 - 4/2016 Role Principal Investigator Grant Detail A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ from a CMV-Seropositive Donor Protocol for Phase 2 Study of ASP0113

  • Publications

      Journal Article

      Jay C, Pugh J, Halff G, Abrahamian G, Cigarroa F, Washburn K. Graft quality matters: Survival after simultaneous liver-kidney transplant according to KDPI Clinical Transplantation 2017 Mar;. Fiorentino TV, Owston M, Abrahamian G, La Rosa S, Marando A, Perego C, Di Cairano ES, Finzi G, Capella C, Sessa F, Casirahi F, Paez An, Adivi A, Davalli A, Fiorina P, Mendoza RG, Comuzzie AG, DeFronzo RA, Halff G, Dick EJ, Folli F. Chronic continuous exenatide infusion does not cause pancreatic inflammation and ductal hyperplasia in non-human primates (Baboons: Papio Hamadryas) Am J Pathology 2015 Jan;185:139-150.

  • Clinical

    Provider profile

    Board Certifications

    • American Board of Surgery
map image

UT Health San Antonio

7703 Floyd Curl Drive
San Antonio, TX 78229

210-567-7000

We make lives better ©

We're a part of UT Health San Antonio, provider of comprehensive health,  dental, &  cancer care,  advanced academics,  and  life-saving research.

Web Privacy | Links from websites affiliated with The University of Texas Health Science Center at San Antonio's website (uthscsa.edu) to other websites do not constitute or imply university endorsement of those sites, their content, or products and services associated with those sites. The content on this website is intended to be used for informational purposes only. Health information on this site is not meant to be used to diagnose or treat conditions. Consult a health care provider if you are in need of treatment.